Study

Bryan Johnson recaps a Baseten longevity event

Bryan Johnson

PUBLIC REACTION / EVENT RECAP; NOT A CONTROLLED STUDY Tier 3 2026

PUBLIC REACTION: Johnson says more than 3,500 people applied for 150 Baseten event places and attendees used bioage tests; he reports no individual results, protocol change, or clinical outcome.

DesignPUBLIC REACTION / EVENT RECAP; NOT A CONTROLLED STUDY
TierTier 3, Ingredient RCT (matching dose)
Year2026
JournalSelf-published — x.com/bryan_johnson
N1
PublishedAug 29, 2026
Added to NO1GEVITYSep 2, 2026

On 29 August 2026, Bryan Johnson posted a short recap of a longevity event with Baseten. He says more than 3,500 people applied for 150 places and that attendees were interested in bioage tests. He also lists discussion themes: doing ambitious work, using health to support performance, changing social norms around valuing life, and making health trade-offs with data. The post names Sarah Guo as a good fit for the event and thanks several organizers. It does not identify the bioage test, report participant-level results, state how many tests were completed, or provide a prespecified analysis. It also supplies no intervention, comparator, follow-up period, adverse-event report, or clinical endpoint. The application count is an event statistic, not a health result. This item records a public reaction and event recap rather than a self-experiment. It offers no basis for judging whether any bioage measure is valid, responsive to an intervention, or related to lifespan. No ingredient or biomarker evidence-grade change follows. The only durable update is that Johnson is using public events and bioage testing as part of his communication strategy.

Amazing longevity event with @baseten
Critic notes

No relevant critic article, PubMed paper, or preprint dated 27 August–2 September 2026 was found. The post contains no human trial result and does not justify an evidence-grade upgrade.

Read the source

Cited by

1 encyclopedia entries reference this study.